Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke

Thaler, David E.; Ruthazer, Robin; Weimar, Christian; Serena, Joaquín; Mattle, Heinrich P.; Nedeltchev, Krassen; Mono, Marie-Luise; Di Angelantonio, Emanuele; Elkind, Mitchell S.V.; Di Tullio, Marco R.; Homma, Shunichi; Michel, Patrik; Meier, Bernhard; Furlan, Anthony J.; Lutz, Jennifer S.; Kent, David M. (2014). Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke. Neurology, 83(21), pp. 1954-1957. Lippincott Williams & Wilkins 10.1212/WNL.0000000000001007

Text Neurology-2014-Thaler-1954-7.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (220kB) | Request a copy

Objective: We examined the influence of clinical, radiologic, and echocardiographic characteristics on antithrombotic choice in patients with cryptogenic stroke (CS) and patent foramen ovale (PFO), hypothesizing that features suggestive of paradoxical embolism might lead to greater use of anticoagulation.

Methods: The Risk of Paradoxical Embolism Study combined 12 databases to create the largest dataset of patients with CS and known PFO status. We used generalized linear mixed models with a random effect of component study to explore whether anticoagulation was preferentially selected based on the following: (1) younger age and absence of vascular risk factors, (2) “high-risk” echocardiographic features, and (3) neuroradiologic findings.

Results: A total of 1,132 patients with CS and PFO treated with anticoagulation or antiplatelets were included. Overall, 438 participants (39%) were treated with anticoagulation with a range (by database) of 22% to 54%. Treatment choice was not influenced by age or vascular risk factors. However, neuroradiologic findings (superficial or multiple infarcts) and high-risk echocardiographic features (large shunts, shunt at rest, and septal hypermobility) were predictors of anticoagulation use.

Conclusion: Both antithrombotic regimens are widely used for secondary stroke prevention in patients with CS and PFO. Radiologic and echocardiographic features were strongly associated with treatment choice, whereas conventional vascular risk factors were not. Prior observational studies are likely to be biased by confounding by indication.

Interest & Impact

Downloads

0 since deposited on 06 Feb 2015
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item